Abstract:BACKGROUND: In recent years, there has been rapid growth in pharmaceutical spending in China. In addition, the country faces many challenges with regards to the quality, pricing and affordability of drugs. Pricing and reimbursement are important aspects of pharmaceutical policy that must be prioritised in order to address the many challenges.METHODS: This review draws on multiple sources of information. A review of the academic and grey literature along with official government statistics were combined with information from seminars held by China's State Council Development Research Center to provide an overview of pharmaceutical pricing and reimbursement in China.RESULTS: Pricing and reimbursement policy were analysed through a framework that incorporates supply-side policies, proxy-demand policies and demand-side policies. China's current pharmaceutical policies interact in such a way to create dysfunction in the form of high prices, low drug quality, irrational prescribing and problems with access. Finally, the country's fragmented regulatory environment hampers pharmaceutical policy reform.CONCLUSIONS: The pricing and reimbursement policy landscape can be improved through higher drug quality standards, greater market concentration, an increase in government subsidies, quality-oriented tendering, wider implementation of the zero mark-up policy, through linking reimbursement with rational prescribing, and the promotion of health technology assessment and comparative effectiveness research. Addressing broader issues of regulatory fragmentation, the lack of transparency and corruption will help ensure that policies are created in a coherent, evidence-based fashion.

On the Concept of Inexpensive Drugs

Role of Policy Interventions and Market Mechanisms in the Control of Drug Expenses in China

Comparison of the Retail Drug Prices between China and Other Developed Countries or Districts

Comparative Study on the Policies of Drug Price and Expenditure Control in China and Other Countries

Causes of the unduly rapid growth of drug expenses in China and countermeasures

International Experiences of Medicines Insurance Payment Pricing Mechanisms and the Implications to China

Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts

Enlightenment of Drug Pricing and Drug Administration Policy in UK

Experiences on Reimbursement of Classified Drugs in Other Countries and Areas

Issues in drug pricing, reimbursement, and access in China with references to other Asia-Pacific region.

Issues in Drug Pricing,Reimbursement and Access in China from the International Perspectives

International Comparison of Drug Price Level in China

Development and Practice of Pharmacoeconomics in Aisa-Pacific Region

The Development and Thinking of Drug Centralized Procurement Policy in China

Concepts for the Construction of a New National Drug Service System

Experience and Enlightenment of Drug Price Regulation in Germany,Japan and Taiwan Area of China

Specific Role of Pharmacoeconomics in the Medical Reform Program Implementation

A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent Originators

International Experience in the Management of OTC Drugs' Reimbursement

Is the prescribing behavior of Chinese physicians driven by financial incentives?

Analysis of the "regulation of Drug Price Difference (trial Implementation)" in China